Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu, Eugene Lifshits, Ana M. Borras, Christopher-Michael Gale, George N. Naumov, B.Y. Yeap, E. Jarrell, Jing Sun, Samuel Tracy, Xiao‐Jun Zhao, John V. Heymach, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Jänne

Journal of Clinical Investigation, 2006

Massachusetts General Hospital, Dana-Farber Cancer Institute, Center for Orthopaedics, Boston Children's Hospital, Harvard University Press, Boston Children's Museum, Beth Israel Deaconess Medical Center, The University of Texas MD Anderson Cancer Center, Thoracic Surgery Foundation, Harvard University, Center for Systems Biology

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with Journal of Clinical Investigation. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

457

Citations

View on Google Scholar

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back